Research demonstrates a 70% increase in peak torque and a significant acceleration in healing following muscle injury in aged subjects
The key to unlocking DSIPs restorative potential, including its role in physical recovery, is consistency, high-quality product/formulation, and proper dosing rather than chasing higher numbers
Improves Joint Mobility : By repairing ligaments, it restores function and reduces pain in knees, shoulders, and elbows
Novo Nordisk files for FDA approval for CagriSema, the first once-weekly combination of GLP1 and amylin analogues owenhaskins Dec 19, 2025 2 min read Novo Nordisk has submitted a New Drug Application (NDA) to the FDA for once-weekly CagriSema (cagrilintide 2.4 mg and semaglutide 2.4 mg) injection, to be used with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity or overweight in the presence of at least one weight-related comorbid condition